These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19869284)

  • 1. STUDIES ON IMMUNITY TO PNEUMOCOCCUS MUCOSUS (TYPE III) : I. ANTIBODY RESPONSE OF RABBITS IMMUNIZED WITH TYPE III PNEUMOCOCCUS.
    Tillett WS
    J Exp Med; 1927 Mar; 45(4):713-26. PubMed ID: 19869284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STUDIES ON IMMUNITY TO PNEUMOCOCCUS MUCOSUS (TYPE III) : III. INCREASED RESISTANCE TO TYPE III INFECTION INDUCED IN RABBITS BY IMMUNIZATION WITH R AND S FORMS OF PNEUMOCOCCUS.
    Tillett WS
    J Exp Med; 1927 Jul; 46(2):343-56. PubMed ID: 19869342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. REACTIONS OF RABBITS TO INTRACUTANEOUS INJECTIONS OF PNEUMOCOCCI AND THEIR PRODUCTS : II. RESISTANCE TO INFECTION.
    Julianelle LA
    J Exp Med; 1930 Feb; 51(3):449-62. PubMed ID: 19869703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACTIVE AND PASSIVE IMMUNITY TO PNEUMOCOCCUS INFECTION INDUCED IN RABBITS BY IMMUNIZATION WITH R PNEUMOCOCCI.
    Tillett WS
    J Exp Med; 1928 Nov; 48(6):791-804. PubMed ID: 19869521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS : V. THE IMMUNOLOGICAL SPECIFITY OF AN ANTIGEN PREPARED BY COMBINING THE CAPSULAR POLYSACCHARIDE OF TYPE III PNEUMOCOCCUS WITH FOREIGN PROTEIN.
    Avery OT; Goebel WF
    J Exp Med; 1931 Jul; 54(3):437-47. PubMed ID: 19869930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STUDIES ON IMMUNITY TO PNEUMOCOCCUS MUCOSUS (TYPE III) : II. THE INFECTIVITY OF TYPE III PNEUMOCOCCUS FOR RABBITS.
    Tillett WS
    J Exp Med; 1927 May; 45(6):1093-106. PubMed ID: 19869308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOME ULTRAVIOLET PHOTOMICROGRAPHS OF B. SUBTILIS.
    Wyckoff RW; Ter Louw AL
    J Exp Med; 1931 Jul; 54(3):449-51. PubMed ID: 19869931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STUDIES OF THE PNEUMOCOCCUS AND ALLIED ORGANISMS WITH REFERENCE TO THEIR OCCURRENCE IN THE HUMAN MOUTH.
    Buerger L
    J Exp Med; 1905 Aug; 7(5):497-546. PubMed ID: 19867012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. THE APPLICATION OF THE REACTION OF AGGLUTINATION TO THE PNEUMOCOCCUS.
    Collins KR
    J Exp Med; 1905 Aug; 7(5):420-9. PubMed ID: 19867008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. THE PRODUCTION OF PURPURA BY DERIVATIVES OF PNEUMOCOCCUS : III. FURTHER STUDIES ON THE NATURE OF THE PURPURA-PRODUCING PRINCIPLE.
    Julianelle LA; Reimann HA
    J Exp Med; 1927 Mar; 45(4):609-18. PubMed ID: 19869276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IMMUNOLOGICAL PROPERTIES OF A TYPICAL (S-PRODUCING) AND A DEGRADED (NON-S-PRODUCING) STRAIN OF TYPE II PNEUMOCOCCUS WITH SPECIAL REFERENCE TO PROTECTIVE ANTIBODIES.
    Gaspari EL; Fleming WL; Neill JM
    J Exp Med; 1927 Jun; 46(1):101-11. PubMed ID: 19869316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STUDIES ON NATURAL IMMUNITY TO PNEUMOCOCCUS TYPE III : II. CERTAIN DISTINGUISHING PROPERTIES OF TWO STRAINS OF PNEUMOCOCCUS TYPE III VARYING IN THEIR VIRULENCE FOR RABBITS, AND THE REAPPEARANCE OF THESE PROPERTIES FOLLOWING R-->S RECONVERSION OF THEIR RESPECTIVE ROUGH DERIVATIVES.
    Shaffer MF; Enders JF; Wu CJ
    J Exp Med; 1936 Jul; 64(2):281-305. PubMed ID: 19870536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPECIFIC ANTIBODY RESPONSE OF HUMAN SUBJECTS TO INTRACUTANEOUS INJECTION OF PNEUMOCOCCUS PRODUCTS.
    Finland M; Sutliff WD
    J Exp Med; 1932 May; 55(6):853-65. PubMed ID: 19870036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHEMOIMMUNOLOGICAL STUDIES ON THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS : I. THE ISOLATION AND PROPERTIES OF THE ACETYL POLYSACCHARIDE OF PNEUMOCOCCUS TYPE I.
    Avery OT; Goebel WF
    J Exp Med; 1933 Nov; 58(6):731-55. PubMed ID: 19870226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. THE ANTIGENIC PROPERTIES OF SOLUTIONS OF PNEUMOCOCCUS.
    Avery OT; Neill JM
    J Exp Med; 1925 Aug; 42(3):355-65. PubMed ID: 19869058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DEVELOPMENT OF AGGLUTININS AND PROTECTIVE ANTIBODIES IN RABBITS, AFTER INHALATION OF TYPE II PNEUMOCOCCI.
    Stillman EG
    J Exp Med; 1930 Jul; 52(2):225-34. PubMed ID: 19869761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A COMPARISON OF CUTANEOUS SENSITIZATION AND ANTIBODY FORMATION IN RABBITS IMMUNIZED BY INTRAVENOUS OR INTRADERMAL INJECTIONS OF INDIFFERENT OR HEMOLYTIC STREPTOCOCCI AND PNEUMOCOCCI.
    Angevine DM
    J Exp Med; 1941 Jan; 73(1):57-66. PubMed ID: 19871065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. REACTIONS OF RABBITS TO INTRACUTANEOUS INJECTIONS OF PNEUMOCOCCI AND THEIR PRODUCTS : VIII. THE INTERRELATIONSHIPS OF HYPERSENSITIVENESS TO PNEUMOCOCCUS AND STREPTOCOCCUS.
    Julianelle LA; Morris MC
    J Exp Med; 1932 May; 55(6):867-76. PubMed ID: 19870037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AN IMMUNOLOGICAL STUDY OF PNEUMOCOCCUS MUCOSUS.
    Hanes FM
    J Exp Med; 1914 Jan; 19(1):38-51. PubMed ID: 19867748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CUTANEOUS REACTIONS IN RABBITS TO THE TYPE-SPECIFIC CAPSULAR POLYSACCHARIDES OF PNEUMOCOCCUS.
    Francis T; Tillett WS
    J Exp Med; 1931 Sep; 54(4):587-96. PubMed ID: 19869942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.